Overall Net-Zero Target: Takeda Pharmaceutical Company Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2040. Near-Term Targets: Takeda Pharmaceutical Company commits to reduce absolute scope 1 and 2 GHG emissions 65% by FY2030 from a FY2016 base year.* Takeda Pharmaceutical Company also commits to reduce absolute scope 3 GHG emissions 25% by FY2030 from a FY2022 base year. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Takeda Pharmaceutical Company commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2035 from a FY2016 base year.* Takeda Pharmaceutical Company also commits to reduce absolute scope 3 GHG emissions 90% by FY2040 from a FY2022 base year. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.